Valuation : Pathkey.AI Ltd

Market Cap 47.26M 34.07M 29.32M 27.58M 25.2M 47.14M 3.22B 326M 126M 1.65B 128M 125M 5.32B P/E 2025
-3.77x
P/E 2026 -8.1x
Enterprise Value 43.85M 31.61M 27.2M 25.59M 23.38M 43.74M 2.98B 302M 117M 1.53B 119M 116M 4.93B EV / Sales 2025
21.1x
EV / Sales 2026 1,648x
Free-Float
59.45%
Yield 2025 *
-
Yield 2026 -
1 day-2.86%
1 week-17.07%
Current month-17.07%
1 month+9.68%
3 months-10.53%
6 months+54.55%
Current year+112.50%
1 week 0.03
Extreme 0.032
0.04
1 month 0.03
Extreme 0.032
0.05
Current year 0.02
Extreme 0.016
0.08
1 year 0.01
Extreme 0.014
0.08
3 years 0.01
Extreme 0.014
0.08
5 years 0.01
Extreme 0.014
0.2
10 years 0.01
Extreme 0.014
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 1994-01-16
Chief Executive Officer - 2026-05-10
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman - 2025-10-20
Director/Board Member - 2025-10-20
Chairman - 2025-11-25
Change 5-day change 1-year change 3-year change Capi.($)
-2.86%-17.07%+30.77%-24.44% 34.07M
-3.27%-0.58%+0.79%+23.65% 44.54B
-2.30%-5.66%-43.50%+131.30% 13.1B
-0.14%+0.97%-12.21%+86.15% 5.85B
-1.61%+2.37%+57.42% - 4.25B
+0.31%+6.91% - - 2.1B
-1.29%+3.90%+7.04%-41.73% 1.57B
-0.35%-1.46%-34.88% - 1.1B
+0.59%+1.58%+22.62%+147.60% 1.02B
-5.69%-5.39%+41.60%+43.96% 931M
Average -1.68%-2.21%+7.74%+52.36% 7.45B
Weighted average by Cap. -2.59%-0.72%-4.50%+50.75%

Financials

2025 2026
Net sales 322K 232K 200K 188K 172K 321K 21.91M 2.22M 862K 11.24M 872K 853K 36.22M 47.63K 34.33K 29.54K 27.8K 25.39K 47.5K 3.24M 328K 127K 1.66M 129K 126K 5.36M
Net income -1.45M -1.04M -898K -845K -772K -1.44M -98.53M -9.98M -3.87M -50.55M -3.92M -3.83M -163M -3.65M -2.63M -2.27M -2.13M -1.95M -3.64M -249M -25.19M -9.77M -128M -9.89M -9.67M -411M
Net Debt -25.17K -18.14K -15.61K -14.69K -13.42K -25.1K -1.71M -174K -67.34K -879K -68.12K -66.63K -2.83M -3.41M -2.46M -2.12M -1.99M -1.82M -3.4M -232M -23.51M -9.12M -119M -9.23M -9.03M -384M
Logo Pathkey.AI Ltd
Pathkey.AI Ltd, formerly Opyl Limited, is an artificial intelligence (AI) company. The Company leverages data and technology to transform the landscape of clinical trials and medical research. It is a digital health company specializing in leveraging artificial intelligence technologies to elevate clinical trial design and forecast outcomes, empowering clinical researchers, biopharmaceutical corporations, and medical investors to enhance trial design, drug development, and market delivery. Its Social Media Insights solution captures and analyses online public conversations from people living with a medical condition, healthcare professionals, carers, and researchers. Its TrialKey platform provides users access to tailored and actionable steps to address critical trial challenges. The Company specializes in applying AI and predictive analytics to social media to accelerate therapy adoption and market development in the healthcare industry.
Employees
-
Date Price Change Volume
26-09-06 A$0.0340 -2.86% 1,657,385
26-09-04 A$0.0350 -5.41% 4,090,557
26-09-03 A$0.0370 -9.76% 1,798,148
26-09-02 A$0.0410 +5.13% 1,016,932
26-09-01 A$0.0390 -4.88% 2,397,954